<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WUEJWPNR</identifier><date>2014</date><creator>Bavčar-Vodovnik, Tanja</creator><creator>Kovač, Viljem</creator><creator>Milič, Ana</creator><creator>Vrankar, Martina</creator><creator>Zwitter, Matjaž</creator><relation>documents/doc/W/URN_NBN_SI_doc-WUEJWPNR_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WUEJWPNR_001.txt</relation><format format_type="issue">4</format><format format_type="volume">48</format><format format_type="type">article</format><format format_type="extent">str. 369-380, IV</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">1882491</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WUEJWPNR</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">gemicitabin</subject><subject language_type_id="eng">induction chemotherapy</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">nedrobnocelični rak</subject><subject language_type_id="eng">non-small cell lung cancer</subject><subject language_type_id="slv">pljučni rak</subject><subject language_type_id="eng">radiation therapy</subject><subject language_type_id="eng">randomized clinical trial</subject><title>Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer</title><title>a randomized phase II clinical trial</title></Record>